Compare StocksCB vs PFE

Chubb Limited (CB) vs Pfizer Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-06-19, CB is undervalued at $323, with a DCF intrinsic value of $533 and a margin of safety of 39%. PFE is overvalued at $25, with an intrinsic value of $22 and a margin of safety of -12%. Of the two, CB has the wider margin of safety.

CB
Chubb Limited
$323.40
VS
PFE
Pfizer Inc.
$25.21

Rewards

CB
  • Chubb Limited scores 100/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Each dollar of retained earnings has created $2.32 of earning power — management is an exceptional capital allocator.
  • FCF yield of 10.1% is historically attractive — the business generates significant cash relative to its price.
PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • FCF yield of 8.6% is historically attractive — the business generates significant cash relative to its price.
  • Trailing P/E of 19.2x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.

Risks

CB
  • PEG ratio of 2.89 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 0.96 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • Insiders have sold $8.8M worth of stock in the past 3 months — significant insider liquidation.
PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 13.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Free cash flow has declined at a 29.6% CAGR over the past 4 years — a concerning trend.

Key Valuation Metrics

Learn more →
CB
PFE
Valuation
$12.62B
Free Cash Flow
$12.38B
10.06%
FCF Yield
8.61%
11.44
Trailing P/E
19.24
11.06
Forward P/E
8.91
Quality & Moat
9.47%
ROIC
10.19%
15.43%
ROE
8.31%
31.00%
Gross Margin
74.80%
2.89
PEG Ratio
13.77
Balance Sheet Safety
0.22
Net Debt / Equity
0.57
N/A
Interest Coverage
N/A
1.22
Net Debt / EBITDA
2.03
1.24%
Dividend Yield
6.61%
CB: 6Ties: 2PFE: 4
CBPFE

Historical Fundamentals

Learn more →
CB

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
CB
$1.26
created per $1 retained over 3 years
Value Creator
Σ Retained
$24.27B
Δ Market Cap
+$30.61B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-146.18B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
CB
39.4% Margin of Safety
Price is 39.4% below estimated fair value
Current Price: $323.40
Fair Value: $533.31
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
12.3% Overvalued
Price is 12.3% above estimated fair value
Current Price: $25.21
Fair Value: $22.46
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
CB

What growth rate is the market pricing in at $323?

+2.7%
Market-Implied Owner Earnings Growth
Standard FCF implies -0.1%

The market implies +2.7% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding -0.1%, reflecting heavy growth investment expected to generate future returns.

PFE

What growth rate is the market pricing in at $25?

+5.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +4.5%

The market implies +5.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +4.5%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
CB
100/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Reinvestment Efficiency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
CB
-2.47
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
CB
Insiders 9.4%Institutions 84.9%Retail & Other 5.7%
No. of Institutional Holders2,726
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 69.4%Retail & Other 30.5%
No. of Institutional Holders3,744
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
CB
0
Buys (3M)
1
Buys (12M)
Total value (12M): $114,665
CORBAT MICHAEL L
Director
$114,665
@ $269.80 · 2025-07-25
KEOGH JOHN W
President
$2.87M
@ $293.01 · 2025-06-06
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
CB
3
Sells (3M)
17
Sells (12M)
Total value (12M): $50.11M
ORTEGA JUAN LUIS
Officer
$1.25M
@ $322.08 · 2026-06-08
KEOGH JOHN W
President
$7.39M
@ $321.51 · 2026-05-27
ATIEH MICHAEL G
Director
$190,468
@ $329.53 · 2026-05-21
STEIMER OLIVIER
Director
$658,600
@ $329.30 · 2026-03-19
OHSIEK GEORGE F
Officer
$250,408
@ $325.21 · 2026-03-06
JOHNS BRYCE L
Officer
$504,925
@ $336.62 · 2026-03-04
WAYLAND JOSEPH F
General Counsel
$2.57M
@ $336.44 · 2026-03-03
OHSIEK GEORGE F
Officer
$1.67M
@ $325.43 · 2026-02-13
GREENBERG EVAN G
Chief Executive Officer
$5.00M
@ $335.09 · 2026-02-12
BOROUGHS TIMOTHY ALAN
Chief Investment Officer
$9.23M
@ $331.98 · 2026-02-06
GREENBERG EVAN G
Chief Executive Officer
$4.99M
@ $331.47 · 2026-02-05
ORTEGA JUAN LUIS
Officer
$1.29M
@ $295.04 · 2025-12-02
ORTEGA JUAN LUIS
Officer
$253,666
@ $293.59 · 2025-12-02
LUPICA JOHN J
Officer
$4.85M
@ $296.45 · 2025-11-14
WAYLAND JOSEPH F
General Counsel
$1.73M
@ $297.08 · 2025-11-13
LUPICA JOHN J
Officer
$6.66M
@ $281.00 · 2025-10-27
LUPICA JOHN J
Officer
$1.60M
@ $290.06 · 2025-07-01
ATIEH MICHAEL G
Director
$154,707
@ $287.56 · 2025-06-16
WAYLAND JOSEPH F
General Counsel
$1.54M
@ $293.16 · 2025-06-04
KEOGH JOHN W
President
$24.69M
@ $290.24 · 2025-05-21
ORTEGA JUAN LUIS
Officer
$1.90M
@ $292.13 · 2025-05-20
WAYLAND JOSEPH F
General Counsel
$3.61M
@ $294.82 · 2025-03-20
BOROUGHS TIMOTHY ALAN
Officer
$4.37M
@ $296.12 · 2025-03-18
OHSIEK GEORGE F
Officer
$221,583
@ $290.41 · 2025-03-14
WAYLAND JOSEPH F
General Counsel
$2.87M
@ $286.96 · 2025-03-04
OHSIEK GEORGE F
Officer
$269,503
@ $267.63 · 2025-02-11
GREENBERG EVAN G
Chief Executive Officer
$17.55M
@ $288.42 · 2024-09-09
WAYLAND JOSEPH F
General Counsel
$1.89M
@ $287.07 · 2024-09-05
ATIEH MICHAEL G
Director
$75,035
@ $287.49 · 2024-09-03
LUPICA JOHN J
Officer
$4.28M
@ $285.49 · 2024-09-03
ORTEGA JUAN LUIS
Officer
$1.07M
@ $273.06 · 2024-08-20
ENNS PETER C
Chief Financial Officer
$2.18M
@ $266.06 · 2024-06-20
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
1
Sells (3M)
1
Sells (12M)
Total value (12M): $51,400
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
CB
FearGreed
😏Greed(65/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
CB
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (65)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
View CB Full AnalysisView PFE Full Analysis

Frequently Asked Questions: CB vs PFE

Is Chubb Limited or Pfizer Inc. more undervalued in 2026?

Based on our discounted cash flow model, CB trades at a 39.4% margin of safety (intrinsic value $533 vs. price $323), compared to PFE's -12.3% margin of safety (intrinsic $22 vs. $25).

Which stock has a wider economic moat, Chubb Limited or Pfizer Inc.?

CB scores 100/100 (Wide moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Chubb Limited in financial distress?

CB's Altman Z-Score of 1.0 places it in the Distress zone, signaling elevated bankruptcy risk. PFE scores 2.1 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Chubb Limited or Pfizer Inc.?

Chubb Limited (CB) generates a 10.1% free cash flow yield, compared to Pfizer Inc.'s 8.6%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Chubb Limited or Pfizer Inc.?

PFE earns 10.2% ROIC versus CB's 9.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Chubb Limited's or Pfizer Inc.'s?

CB's dividend earns a safety score of 94/100 (Very Safe), compared to PFE's 24/100 (Unsafe). CB has raised its dividend for 3 consecutive years.